Skip to main content
Search
Search
Enter the terms you wish to search for.
Check our social media on linkedin (opens in a new window)
Check our social media on youtube (opens in a new window)
Register
Login
Join
About Us
Membership
Fellows Program
Save
Connect
Events & Programing
Jobs
Sponsorship
Advocate
Contact Us
Check our social media on linkedin (opens in a new window)
Check our social media on youtube (opens in a new window)
Login
Register
Join
About Us
Membership
Fellows Program
Save
Connect
Events & Programing
Jobs
Sponsorship
Advocate
Contact Us
Join
About Us
Membership
Fellows Program
Save
Connect
Events & Programing
Jobs
Sponsorship
Advocate
Contact Us
Home
membership directory
corporate
3960139
Membership Directory - Corporate
Genexgen Inc.
About
Genexgen is developing first epigenetic therapy to drug MYD88, a master node in innate immune response, for treating HLH, a rare hyper-inflammatory condition.
